Individualizing Type 2 Diabetes Treatment: Applying the Latest Evidence in Consideration of Patient Characteristics

This activity is provided by Paradigm Medical Communications, LLC.

This activity is supported by independent educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC and Lilly.

Scroll to the Bottom of this Information to Begin this Course

Release date: May 16, 2017

Valid through: May 16, 2018

Specialty: Internal Medicine

Topic: Type 2 Diabetes Mellitus

Media: Internet

Estimated Time to Complete Activity: 1.5 hours

Target Audience

This activity has been designed to address the educational needs of physicians specializing in internal medicine. It may also be of benefit to nurse practitioners, PAs, and other healthcare professionals (HCPs) who are interested in optimal management of type 2 diabetes mellitus.

Learning Objectives

Upon proper completion of this activity, participants should be better able to:

  • Review current guideline recommendations and available data to support appropriate individualized type 2 diabetes management based on patient clinical characteristics and preferences.
  • Evaluate the benefit/risk profiles of newer type 2 diabetes therapies.
  • Assess data about the effects of newer type 2 diabetes therapies on macrovascular and microvascular outcomes.

Table of Contents

Applying Guideline Recommendations for Individualizing Care and Personalizing Glycemic Targets to Clinical Practice
Incorporating GLP-1 Receptor Agonists, DPP-4 Inhibitors, SGLT-2 Inhibitors into Individualized Treatment Regimens
Evidence-based Evaluation of the Significance of Macrovascular and Microvascular Outcomes Data
Q&A

Credit Available

  • Physicians — maximum of 1.5 AMA PRA Category 1 Credits

All other healthcare professionals completing this course will be issued a statement of participation.

Faculty

Anne L. Peters, MD (Chair)

Director, USC Clinical Diabetes Program
Professor, Keck School of Medicine of USC
Los Angeles, CA

Yehuda Handelsman, MD, FACP, FACE, FNLA

Medical Director and Clinical Investigator
The Metabolic Institute of America
Tarzana, CA

Javier Morales, MD, FACP, FACE

Associate Clinical Professor of Medicine
Hofstra Northwell School of Medicine at Hofstra University
Hempstead, NY
Vice President
Advanced Internal Medicine Group, PC
East Hills, NY

Physician Accreditation Statement

Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physician Credit Designation Statement

Paradigm Medical Communications, LLC designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PA Continuing Education

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1.5 Category 1 credits for completing this activity.

Nurse Practitioner Continuing Education

The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.

Disclosures of Conflicts of Interest

In accordance with Accreditation Council for Continuing Medical Education requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below.

Anne L. Peters, MD (Chair)
  • Grant/Research Support: Dexcom, Inc
  • Retained Consultant: Abbott Diabetes Care; Becton, Dickinson and Company; Boehringer Ingelheim; Eli Lilly and Company; Janssen Pharmaceuticals, Inc; Lexicon Pharmaceuticals, Inc; Merck & Co., Inc; Novo Nordisk; Omada Health; OptumRx Inc; Perrigo Company plc; Roche; Sanofi
  • Speakers Bureau: Abbott Diabetes Care; Becton, Dickinson and Company; Boehringer Ingelheim; Eli Lilly and Company; Janssen Pharmaceuticals, Inc; Lexicon Pharmaceuticals, Inc; Merck & Co., Inc; Novo Nordisk; Omada Health; OptumRx Inc; Perrigo Company plc; Roche; Sanofi
  • Other (Trainer): Medtronic; Tandem Diabetes Care, Inc (Spouse)
Yehuda Handelsman, MD, FACP, FACE, FNLA
  • Grant/Research Support: Amarin Corporation; Amgen Inc; AstraZeneca; Bristol-Myers Squibb; Boehringer Ingelheim; Boehringer Ingelheim-Lilly; Eisai Co, Ltd; Intarcia Therapeutics, Inc; Janssen Pharmaceuticals, Inc; Lexicon Pharmaceuticals, Inc; Eli Lilly and Company; Merck & Co., Inc; Merck-Pfizer; Novo Nordisk; Regeneron Pharmaceuticals, Inc; Sanofi
  • Retained Consultant: Amarin Corporation; Amgen Inc; AstraZeneca; Bristol-Myers Squibb; Boehringer Ingelheim; Boehringer Ingelheim-Lilly; Eisai Co, Ltd; Intarcia Therapeutics, Inc; Janssen Pharmaceuticals, Inc; Lexicon Pharmaceuticals, Inc; Eli Lilly and Company; Merck & Co., Inc; Merck-Pfizer; Novo Nordisk; Regeneron Pharmaceuticals, Inc; Sanofi
  • Speakers Bureau: Amarin Corporation; Amgen Inc; AstraZeneca; Bristol-Myers Squibb; Boehringer Ingelheim; Boehringer Ingelheim-Lilly; Eisai Co, Ltd; Intarcia Therapeutics, Inc; Janssen Pharmaceuticals, Inc; Lexicon Pharmaceuticals, Inc; Eli Lilly and Company; Merck & Co., Inc; Merck-Pfizer; Novo Nordisk; Regeneron Pharmaceuticals, Inc; Sanofi
Javier Morales, MD, FACP, FACE
  • Retained Consultant: Abbott Laboratories; Novo Nordisk; Lilly; Janssen Pharmaceuticals, Inc
  • Speakers Bureau: Abbott Laboratories; Novo Nordisk, Lilly, Janssen Pharmaceuticals, Inc

Paradigm Medical Communications, LLC staff members have no financial relationships to disclose.

Independent peer reviewer has no financial relationships to disclose.

Resolution of Conflict of Interest

Paradigm Medical Communications, LLC has implemented a system to resolve conflicts of interest for each CME activity to help ensure content objectivity, independence, fair balance, and that the content is aligned with the interest of the public. Conflicts, if any, are resolved through one or more processes. All CME content in this activity was independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the ACCME’s Standards for Commercial Support of Continuing Medical Education.

Instructions for Participation

To receive a CME certificate of participation, you should:

  • Follow the "Continue" button to go to the Paradigm Medical Communications website, where you will complete the pretest.
  • View the online activity in its entirety.
  • Complete and submit the online posttest and evaluation. You must answer 70% of the posttest questions correctly to earn credit. You will have unlimited opportunities to successfully complete the posttest.

A certificate of participation will be available for download/printing immediately following your successful completion of the posttest and evaluation. Your certificate will be saved on the Paradigm Medical Communications website and will not be available in your freeCME® CME History

For questions regarding CME credit, contact the Paradigm CME Department at (845) 398-5949.

There is no fee required for participation in this activity.

Hardware and Software Requirements

This certified CME activity is designed using HTML5 audio.

Supported Browsers

For Desktops (Windows/Mac)
Internet Explorer 9 or higher, Firefox 28 or higher, Safari 5.1 or higher, Google Chrome 31 or higher, Opera 21 or higher

For Tablets (iPad/android/Surface)
iOS Safari 4 or higher, android 2.3 or higher, IE Mobile 10 or higher

Technical Support: If you have any technical problems or playback issues, email us at contactus@paradigmmc.com.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.

Disclaimer

This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

If included, signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.

As an ACCME-accredited provider, Paradigm Medical Communications, LLC activities must include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC.

Terms of Use and Privacy Policy

Disclaimer

The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. Any views or opinions presented are solely those of the Faculty, and do not necessarily represent those of Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC. Paradigm Medical Communications, LLC, accepts no liability for the content referenced in this activity.

Privacy policy

Paradigm Medical Communications, LLC, is committed to protecting the privacy of those who participate in the activities (herein referred to as “website") located at www.paradigmmc.com. The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.

Security/safeguarding personal information

This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.

Collection and use of your personal information

The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC, to continuously improve the learning experience.

Paradigm Medical Communications, LLC, does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC, will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC, staff members review individual test results to the extent necessary to record and track participants’ credits.

Contact Us

If you have any questions or comments, please email us at contactus@paradigmmc.com.

© 2017 Paradigm Medical Communications, LLC, except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.